What is CVE-2026-50044?

CVE-2026-50044 is a medium-severity vulnerability in Pronetiqs Panduit Intravue, classified under Inadequate Encryption Strength. CVSS score: 6.8/10. Published 2026-07-23.

How severe is CVE-2026-50044?

Medium severity. CVSS v3 base score is 6.8 out of 10.

Vulnerability in Pronetiqs Panduit Intravue

CVE-2026-50044

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

Published 2026-07-23 · last modified 2026-07-27.

CVSS v3 metric

CVSS v3 base score 6.8 (Medium). Vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N.

EPSS exploit prediction

EPSS: 0.001 (2.3th percentile), scored 2026-10-23.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 2nd percentile — 2.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.001 · newest: 0.001 · change: 0.000

Affected products

Pronetiqs Panduit Intravue — versions 0

Weakness classification (CWE)

CWE-326 — Inadequate Encryption Strength

References

www.cisa.gov/news-events/ics-advisories/icsa-26-204-04 (government-resource)

Frequently asked questions

What is CVE-2026-50044?: CVE-2026-50044 is a medium-severity vulnerability in Pronetiqs Panduit Intravue, classified under Inadequate Encryption Strength. CVSS score: 6.8/10. Published 2026-07-23.
How severe is CVE-2026-50044?: Medium severity. CVSS v3 base score is 6.8 out of 10.